SPONTANEOUS OCCURRENCE OF SYMPTOMATIC PAROXYSMAL ATRIAL-FIBRILLATION AND PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA IN UNTREATED PATIENTS

被引:89
作者
CLAIR, WK
WILKINSON, WE
MCCARTHY, EA
PAGE, RL
PRITCHETT, ELC
机构
[1] DUKE UNIV,MED CTR,DEPT MED,DIV CARDIOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT COMMUNITY & FAMILY MED,DIV BIOMETRY & MED INFORMAT,DURHAM,NC 27710
关键词
FIBRILLATION; ATRIAL; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY; TACHYCARDIA; PAROXYSMAL; SUPRAVENTRICULAR; WOLFF-PARKINSON-WHITE SYNDROME;
D O I
10.1161/01.CIR.87.4.1114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Ambulatory outpatients (n = 150) with a history of paroxysmal supraventricular arrhythmia were studied to establish the characteristics of the first recurrence of symptomatic tachycardia (time to first recurrence, heart rate during tachycardia, and observed rhythm that was regular versus irregular) when no antiarrhythmic drug was being taken. Baseline variables were examined to assess their impact on time to first recurrence: index arrhythmia (paroxysmal atrial fibrillation [n = 37] versus paroxysmal supraventricular tachycardia [n = 113]), age (mean +/- SD, 43.3 +/- 16.1 years), female sex (n = 71), or presence of other heart or lung disease (n = 53). Methods and Results. Transtelephonic monitoring of the ECG was used to document the rhythm during recurrences of symptomatic tachycardia. Time to first recurrence of symptomatic tachycardia and heart rate during tachycardia were measured, the observed rhythm was classified as irregular (consistent with paroxysmal atrial fibrillation) or regular (consistent with paroxysmal supraventricular tachycardia), and the hour of recurrence was recorded. Advancing age was significantly associated with a decreasing time to first recurrence (p < 0.001); the estimated increase in the hazard function was 25% with each 10 years of advancing age. After the effect of age was adjusted for, neither the classification of arrhythmia (p > 0.2), presence of other heart or lung disease (p > 0.8), nor sex (p > 0.9) was significantly associated with time to first recurrence. Among patients with paroxysmal supraventricular tachycardia, 6.5% had atrial fibrillation recorded at the next symptomatic arrhythmia; among patients with paroxysmal atrial fibrillation, 11.8% had a regular tachycardia recorded at the next symptomatic arrhythmia. There was a circadian pattern to the hour of occurrence of paroxysmal supraventricular tachycardia but not paroxysmal atrial fibrillation. Conclusions. Age is more important than other clinical variables, including the ECG classification of a paroxysmal supraventricular arrhythmia in predicting the occurrence of symptomatic arrhythmias. Arrhythmias documented by ECG during symptoms are often different from the arrhythmia documented at the time of referral, which may confound interpretation of antiarrhythmic drug effects.
引用
收藏
页码:1114 / 1122
页数:9
相关论文
共 21 条
  • [1] PREVENTION OF SYMPTOMATIC RECURRENCES OF PAROXYSMAL ATRIAL-FIBRILLATION IN PATIENTS INITIALLY TOLERATING ANTIARRHYTHMIC THERAPY - A MULTICENTER, DOUBLE-BLIND, CROSSOVER STUDY OF FLECAINIDE AND PLACEBO WITH TRANSTELEPHONIC MONITORING
    ANDERSON, JL
    GILBERT, EM
    ALPERT, BL
    HENTHORN, RW
    WALDO, AL
    BHANDARI, AK
    HAWKINSON, RW
    PRITCHETT, ELC
    [J]. CIRCULATION, 1989, 80 (06) : 1557 - 1570
  • [2] PAROXYSMAL ATRIAL-FIBRILLATION IN THE WOLFF-PARKINSON-WHITE SYNDROME
    BAUERNFEIND, RA
    WYNDHAM, CR
    SWIRYN, SP
    PALILEO, EV
    STRASBERG, B
    LAM, W
    WESTVEER, D
    ROSEN, KM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1981, 47 (03) : 562 - 569
  • [3] ATRIAL-FIBRILLATION IN PREEXCITATION SYNDROME
    CAMPBELL, RWF
    SMITH, RA
    GALLAGHER, JJ
    PRITCHETT, ELC
    WALLACE, AG
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1977, 40 (04) : 514 - 520
  • [4] TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA WITH ORAL DILTIAZEM
    CLAIR, WK
    WILKINSON, WE
    MCCARTHY, EA
    PRITCHETT, ELC
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) : 562 - 565
  • [5] Coumel P., 1979, CARDIAC ARRHYTHMIAS, P243
  • [6] Fleiss JL., 1981, STAT METHODS RATES P, V2
  • [7] RANDOM AND NONRANDOM BEHAVIOR OF SYMPTOMATIC PAROXYSMAL ATRIAL-FIBRILLATION
    GREER, GS
    WILKINSON, WE
    MCCARTHY, EA
    PRITCHETT, ELC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (05) : 339 - 342
  • [8] FLECAINIDE ACETATE PREVENTS RECURRENCE OF SYMPTOMATIC PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
    HENTHORN, RW
    WALDO, AL
    ANDERSON, JL
    GILBERT, EM
    ALPERT, BL
    BHANDARI, AK
    HAWKINSON, RW
    PRITCHETT, ELC
    [J]. CIRCULATION, 1991, 83 (01) : 119 - 125
  • [9] CIRCADIAN OCCURRENCE OF SYMPTOMATIC PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA IN UNTREATED PATIENTS
    IRWIN, JM
    MCCARTHY, EA
    WILKINSON, WE
    PRITCHETT, ELC
    [J]. CIRCULATION, 1988, 77 (02) : 298 - 300
  • [10] Josephson ME, 1979, CLIN CARDIAC ELECTRO